Objective: To determine cardiovascular risk factors in patients hospitalized for COVID-19. Material and methods: Systematic review that includedobservational studies with cardiovascular disease risk factors in patients hospitalized with COVID-19, with text available, in English or Spanish; letters to the editor, abstracts, documents and clinical trials were excluded, studies without reliable data and duplicate sources. A bibliographic search of literature was conducted in PubMed, MEDLINE and JAMA, from June 12 to 18, 2021, search strategies were evaluated through the program of the Cochrane Manual of systematic reviews. The Mendeley program was used to manage bibliographic references and eliminate studies. The methodological quality of arti...
According to the epidemiological sources of the World Health Organization, in the last decade, among...
The current scenario derived from the COVID-19 infection caused by the virus denominated SARS-CoV-2 ...
Introduction: cardiovascular diseases (CVD) are the leading cause of death in developed and developi...
Introduction: When referring to COVID-19, the respiratory symptoms dominate the discussions and init...
Introducción: El estado de inmunosupresión de los pacientes con enfermedad renal crónica (ERC) ...
Premi Extraordinari de Doctorat concedit pels programes de doctorat de la UAB per curs acadèmic 2016...
Cardiovascular diseases are one of the main causes of mortality worldwide; It was traditionally seen...
Objetivo: analisar as evidências sobre os riscos de adoecimento ocupacional aos quais estão expostos...
Enquadramento: As doenças cardiovasculares são a principal causa de morte, cuja etiologia surge da c...
Introduction: To describe patients´ characteristics of confirmed COVID-19 with mild symptoms dischar...
Objective: Remdesivir has not shown survival benefit for patients with severe COVID-19. However, su...
Introduction: Venous thromboembolic disease is the third cause of cardiovascular disease, being a pu...
Introduction: chronic obstructive pulmonary disease (COPD) is a chronic inflammatory entity characte...
OBJECTIVE: Mortality of diabetic patients is higher than that of the population at large, and mainly...
Objetivo: Identificar o perfil sociodemográfico e clínico de pacientes com COVID-19; mensurar carga ...
According to the epidemiological sources of the World Health Organization, in the last decade, among...
The current scenario derived from the COVID-19 infection caused by the virus denominated SARS-CoV-2 ...
Introduction: cardiovascular diseases (CVD) are the leading cause of death in developed and developi...
Introduction: When referring to COVID-19, the respiratory symptoms dominate the discussions and init...
Introducción: El estado de inmunosupresión de los pacientes con enfermedad renal crónica (ERC) ...
Premi Extraordinari de Doctorat concedit pels programes de doctorat de la UAB per curs acadèmic 2016...
Cardiovascular diseases are one of the main causes of mortality worldwide; It was traditionally seen...
Objetivo: analisar as evidências sobre os riscos de adoecimento ocupacional aos quais estão expostos...
Enquadramento: As doenças cardiovasculares são a principal causa de morte, cuja etiologia surge da c...
Introduction: To describe patients´ characteristics of confirmed COVID-19 with mild symptoms dischar...
Objective: Remdesivir has not shown survival benefit for patients with severe COVID-19. However, su...
Introduction: Venous thromboembolic disease is the third cause of cardiovascular disease, being a pu...
Introduction: chronic obstructive pulmonary disease (COPD) is a chronic inflammatory entity characte...
OBJECTIVE: Mortality of diabetic patients is higher than that of the population at large, and mainly...
Objetivo: Identificar o perfil sociodemográfico e clínico de pacientes com COVID-19; mensurar carga ...
According to the epidemiological sources of the World Health Organization, in the last decade, among...
The current scenario derived from the COVID-19 infection caused by the virus denominated SARS-CoV-2 ...
Introduction: cardiovascular diseases (CVD) are the leading cause of death in developed and developi...